Manuel Pérez‐Encinas

2.0k total citations
46 papers, 533 citations indexed

About

Manuel Pérez‐Encinas is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Manuel Pérez‐Encinas has authored 46 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 27 papers in Genetics and 14 papers in Molecular Biology. Recurrent topics in Manuel Pérez‐Encinas's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (17 papers), Chronic Myeloid Leukemia Treatments (15 papers) and Acute Myeloid Leukemia Research (14 papers). Manuel Pérez‐Encinas is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (17 papers), Chronic Myeloid Leukemia Treatments (15 papers) and Acute Myeloid Leukemia Research (14 papers). Manuel Pérez‐Encinas collaborates with scholars based in Spain, Italy and Poland. Manuel Pérez‐Encinas's co-authors include José Belló, Adrián Mosquera Orgueira, Marta Sonia González, José Ángel Díaz Arias, Santiago Tomé, Rosa de Miguel Buckley, Valentín García‐Gutiérrez, Ana Kerguelen, Alberto Álvarez‐Larrán and Francisca Ferrer‐Marín and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Manuel Pérez‐Encinas

44 papers receiving 521 citations

Peers

Countries citing papers authored by Manuel Pérez‐Encinas

Since Specialization

Citations

This map shows the geographic impact of Manuel Pérez‐Encinas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Pérez‐Encinas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Pérez‐Encinas more than expected).

Fields of papers citing papers by Manuel Pérez‐Encinas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Pérez‐Encinas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Pérez‐Encinas. The network helps show where Manuel Pérez‐Encinas may publish in the future.

Co-authorship network of co-authors of Manuel Pérez‐Encinas

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Pérez‐Encinas. A scholar is included among the top collaborators of Manuel Pérez‐Encinas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Pérez‐Encinas. Manuel Pérez‐Encinas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Redefining the myeloid disease continuum: Machine learning–based development and validation of an integrated multimodal classification of myeloid neoplasms 2025 ·Blood ·(unknown), (unknown), Chien‐Chin Lin, Carmelo Gurnari, Hussein Awada, (unknown), Manuel Pérez‐Encinas, Donal P. McLornan, (unknown), Talha Badar, Bor‐Sheng Ko, Hsin‐An Hou, Wen‐Chien Chou, (unknown), Jaroslaw Maciejewski, Nick Telford, Kiran Batta, Daniel H. Wiseman	0
2	Refining risk prediction in pediatric acute lymphoblastic leukemia through DNA methylation profiling 2024 ·Clinical Epigenetics ·Adrián Mosquera Orgueira, (unknown), (unknown), (unknown), José Ángel Díaz Arias, Marta Sonia González, Manuel Pérez‐Encinas, (unknown), (unknown), Mats Heyman, Gudmar Lönnerholm, Ulrika Norén‐Nyström, Kjeld Schmiegelow, Jessica Nordlund	2
3	DNMT3A/TET2/ASXL1 Mutations are an Age-independent Thrombotic Risk Factor in Polycythemia Vera Patients: An Observational Study 2024 ·Thrombosis and Haemostasis ·(unknown), Ruth Stuckey, (unknown), Marta Sobas, Alberto Álvarez‐Larrán, Francisca Ferrer‐Marín, Manuel Pérez‐Encinas, Gonzalo Carreño‐Tarragona, María Laura Fox, (unknown), Beatriz Cuevas, Juan F. Rodrı́guez, (unknown), Jesús M. González‐Martín, María Teresa Gómez‐Casares, Cristina Bilbao, (unknown)	3
4	Prediction of major bleeding events in 1381 patients with essential thrombocythemia 2023 ·International Journal of Hematology ·Ruth Stuckey, Jean‐Christophe Ianotto, Marco Santoro, Anna Czyż, Manuel Pérez‐Encinas, María Teresa Gómez‐Casares, (unknown), (unknown), (unknown), Krzysztof Lewandowski, (unknown), Jesús M. González‐Martín, Marta Sobas	5
5	Presence of Myeloid Mutations in Patients with Chronic Myeloid Leukemia Increases Risk of Cardiovascular Event on Tyrosine Kinase Inhibitor Treatment 2023 ·Cancers ·Ruth Stuckey, (unknown), (unknown), Manuel Pérez‐Encinas, (unknown), (unknown), (unknown), (unknown), Cristina Bilbao, María Teresa Gómez‐Casares	2
6	A prognostic model based on gene expression parameters predicts a better response to bortezomib-containing immunochemotherapy in diffuse large B-cell lymphoma 2023 ·Frontiers in Oncology ·Adrián Mosquera Orgueira, José Ángel Díaz Arias, (unknown), (unknown), (unknown), (unknown), (unknown), Marta Sonia González, Manuel Pérez‐Encinas, (unknown), (unknown), (unknown)	3
7	Personally Tailored Survival Prediction of Patients With Follicular Lymphoma Using Machine Learning Transcriptome-Based Models 2022 ·Frontiers in Oncology ·Adrián Mosquera Orgueira, (unknown), (unknown), (unknown), José Ángel Díaz Arias, Marta Sonia González, (unknown), (unknown), (unknown), (unknown), Manuel Pérez‐Encinas, Máximo Fraga, Claudio Cerchione, Pablo Mozas, (unknown)	7
8	Personalized Survival Prediction of Patients With Acute Myeloblastic Leukemia Using Gene Expression Profiling 2021 ·Frontiers in Oncology ·Adrián Mosquera Orgueira, (unknown), (unknown), José Ángel Díaz Arias, Marta Sonia González, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Claudio Cerchione, (unknown), Pau Montesinos, Manuel Pérez‐Encinas, (unknown)	24
9	Survival prediction and treatment optimization of multiple myeloma patients using machine-learning models based on clinical and gene expression data 2021 ·Leukemia ·Adrián Mosquera Orgueira, Marta Sonia González, José Ángel Díaz Arias, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Manuel Pérez‐Encinas, (unknown), María‐Victoria Mateos	27
10	Gene expression profiling identifies FLT3 mutation-like cases in wild-type FLT3 acute myeloid leukemia 2021 ·PLoS ONE ·Adrián Mosquera Orgueira, (unknown), (unknown), (unknown), José Ángel Díaz Arias, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Marta Sonia González, Claudio Cerchione, Giovanni Martinelli, Pau Montesinos, Manuel Pérez‐Encinas, (unknown)	11
11	Improved personalized survival prediction of patients with diffuse large B-cell Lymphoma using gene expression profiling 2020 ·BMC Cancer ·Adrián Mosquera Orgueira, José Ángel Díaz Arias, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Marta Sonia González, Manuel Pérez‐Encinas, Máximo Fraga, (unknown)	10
12	The association of germline variants with chronic lymphocytic leukemia outcome suggests the implication of novel genes and pathways in clinical evolution 2019 ·BMC Cancer ·Adrián Mosquera Orgueira, (unknown), (unknown), José Ángel Díaz Arias, (unknown), Manuel Pérez‐Encinas, Catarina Allegue, Elena M. Seco, Ãngel Carracedo, (unknown)	8
13	A prognostic model for survival after salvage treatment with FLAG‐Ida +/− gemtuzumab‐ozogamicine in adult patients with refractory/relapsed acute myeloid leukaemia 2016 ·British Journal of Haematology ·Juan Bergua, Pau Montesinos, (unknown), Pascual Fernández, Josefina Serrano, María José Sayas, (unknown), Raimundo García, (unknown), Manuel Barrios, Celina Benavente, Manuel Pérez‐Encinas, (unknown), Gabriela Rodríguez‐Macías, (unknown), Rebeca Rodríguez‐Veiga, (unknown), (unknown), (unknown), Miguel Á. Sanz, (unknown)	36
14	Oral anticoagulation to prevent thrombosis recurrence in polycythemia vera and essential thrombocythemia 2015 ·Annals of Hematology ·(unknown), Juan Carlos Hernández‐Boluda, Eduardo Arellano‐Rodrigo, Francisco Cervantes, Alberto Álvarez‐Larrán, Montse Gómez, Pere Barba, (unknown), (unknown), Francisca Ferrer‐Marín, Valentín García‐Gutiérrez, Elena Magro, (unknown), Ana Kerguelen, Manuel Pérez‐Encinas, Natàlia Estrada, Rosa Ayala, Carles Besses, Arturo Pereira	41
15	ACUTE MYELOID LEUKEMIA IN PATIENTS 70 AND ABOVE. AZACITIDINE VERSUS INTENSIVE CHEMOTHERAPY 2014 ·Haematologica ·(unknown), Manuel Pérez‐Encinas	1
16	Oligo-secretory myeloma in a patient with ankylosing spondylitis 2009 ·Rheumatology International ·Eva Pérez‐Pampín, J. Campos Franco, Jorge D. Blanco, Manuel Pérez‐Encinas, Antonio Mera	1
17	Linfomas orbitarios: Presentación de nueve casos 2008 ·Archivos de la Sociedad Española de Oftalmología ·(unknown), Manuel Pérez‐Encinas, Francisco González	9
18	Hydroxyurea-induced acute interstitial pneumonitis in a patient with essential thrombocythemia 1999 ·Annals of Hematology ·Alfonso Quintás‐Cardama, Manuel Pérez‐Encinas, Marta Sonia González, (unknown), José Belló	14
19	Correlation and Prognostic Value of Serum Soluble ICAM-1, Beta-2 Microglobulin, and IL-2αR Levels in Non-Hodgkin's Lymphoma 1999 ·Leukemia & lymphoma ·Manuel Pérez‐Encinas, (unknown), (unknown), (unknown), José Belló	8
20	Familial myeloproliferative syndrome 1994 ·American Journal of Hematology ·Manuel Pérez‐Encinas, José Belló, (unknown), Rosa de Miguel Buckley, Santiago Tomé	49

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact